Clinical Trial Update: Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different pre-seasonal BM32 dosing regimens to induce a protective immune response. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Grass Pollen Allergy

Drugs mentioned

• BM32

Snippet

Sponsor: Biomay AG | Conditions: Hypersensitivity | Phase 2 | Status: COMPLETED